CD19 CAR-T cell therapy for relapsed or refractory diffuse large B cell lymphoma: Why does it fail?
Hannah Kinoshita, Catherine M. Bollard, Keri Toner
Topics & Concepts
Chimeric antigen receptorMedicineCAR T-cell therapyLymphomaDiffuse large B-cell lymphomaOncologyCell therapyRefractory (planetary science)CD19Clinical trialPopulationInternal medicineSalvage therapyT cellImmunologyCellChemotherapyAntigenImmune systemBiologyAstrobiologyEnvironmental healthGeneticsCAR-T cell therapy researchVirus-based gene therapy researchViral Infectious Diseases and Gene Expression in Insects